Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Probiotic consumption during puberty mitigates LPS-induced immune responses and protects against stress-induced depression- and anxiety-like behaviors in adulthood in a sex-specific manner.

Murray E, Sharma R, Smith KB, Mar KD, Barve R, Lukasik M, Pirwani AF, Malette-Guyon E, Lamba S, Thomas BJ, Sadeghi-Emamchaie H, Liang J, Mallet JF, Matar C, Ismail N.

Brain Behav Immun. 2019 Jun 15. pii: S0889-1591(19)30338-1. doi: 10.1016/j.bbi.2019.06.016. [Epub ahead of print]

PMID:
31212008
2.

Programming Effects of Pubertal Lipopolysaccharide Treatment in Male and Female CD-1 Mice.

Sharma R, van Mil S, Melanson B, Thomas BJ, Rooke J, Mallet JF, Matar C, Schwarz JM, Ismail N.

J Immunol. 2019 Apr 1;202(7):2131-2140. doi: 10.4049/jimmunol.1801351. Epub 2019 Feb 8.

PMID:
30737275
3.

Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis.

Finianos A, Matar CF, Taher A.

Int J Mol Sci. 2018 Dec 17;19(12). pii: E4070. doi: 10.3390/ijms19124070. Review.

4.

The Immunomodulatory and Anti-Inflammatory Role of Polyphenols.

Yahfoufi N, Alsadi N, Jambi M, Matar C.

Nutrients. 2018 Nov 2;10(11). pii: E1618. doi: 10.3390/nu10111618. Review.

5.

Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes.

Graham DB, Luo C, O'Connell DJ, Lefkovith A, Brown EM, Yassour M, Varma M, Abelin JG, Conway KL, Jasso GJ, Matar CG, Carr SA, Xavier RJ.

Nat Med. 2018 Nov;24(11):1762-1772. doi: 10.1038/s41591-018-0203-7. Epub 2018 Oct 22.

6.

A global visual method for measuring the deterioration of strawberries in MAP.

Matar C, Gaucel S, Gontard N, Guilbert S, Guillard V.

MethodsX. 2018 Jul 20;5:944-949. doi: 10.1016/j.mex.2018.07.012. eCollection 2018.

7.

Sex differences in the peripheral and central immune responses following lipopolysaccharide treatment in pubertal and adult CD-1 mice.

Sharma R, Rooke J, Kolmogorova D, Melanson B, Mallet JF, Matar C, Schwarz J, Ismail N.

Int J Dev Neurosci. 2018 Dec;71:94-104. doi: 10.1016/j.ijdevneu.2018.07.012. Epub 2018 Aug 27.

PMID:
30165175
8.

Anticoagulation for perioperative thromboprophylaxis in people with cancer.

Matar CF, Kahale LA, Hakoum MB, Tsolakian IG, Etxeandia-Ikobaltzeta I, Yosuico VE, Terrenato I, Sperati F, Barba M, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jul 11;7:CD009447. doi: 10.1002/14651858.CD009447.pub3. Review.

9.

Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.

Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Terrenato I, Sperati F, Barba M, Yosuico VE, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jun 19;6:CD006650. doi: 10.1002/14651858.CD006650.pub5. Review.

10.

Anticoagulation for people with cancer and central venous catheters.

Kahale LA, Tsolakian IG, Hakoum MB, Matar CF, Barba M, Yosuico VE, Terrenato I, Sperati F, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jun 1;6:CD006468. doi: 10.1002/14651858.CD006468.pub6. Review.

11.

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.

Hakoum MB, Kahale LA, Tsolakian IG, Matar CF, Yosuico VE, Terrenato I, Sperati F, Barba M, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jan 24;1:CD006649. doi: 10.1002/14651858.CD006649.pub7. Review.

12.

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Barba M, Yosuico VED, Terrenato I, Sperati F, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2017 Dec 29;12:CD006466. doi: 10.1002/14651858.CD006466.pub6. Review.

13.

Perceptions and Attitudes of Cancer Patients and Caregivers Towards Enrollment in Clinical Trials in Lebanon.

Salem R, Matar C, Assi R, Alameddine R, Temraz S, Shamseddine A, Mukherji D.

J Cancer Educ. 2019 Apr;34(2):334-338. doi: 10.1007/s13187-017-1307-3.

PMID:
29196906
14.

Oral manifestations of inflammatory bowel disease.

Mortada I, Leone A, Gerges Geagea A, Mortada R, Matar C, Rizzo M, Hajj Hussein I, Massaad-Massade L, Jurjus A.

J Biol Regul Homeost Agents. 2017 Jul-Sep;31(3):817-821.

PMID:
28958141
15.

Parenteral anticoagulation in ambulatory patients with cancer.

Akl EA, Kahale LA, Hakoum MB, Matar CF, Sperati F, Barba M, Yosuico VED, Terrenato I, Synnot A, Schünemann H.

Cochrane Database Syst Rev. 2017 Sep 11;9:CD006652. doi: 10.1002/14651858.CD006652.pub5. Review.

16.

MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).

Graham ÉA, Mallet JF, Jambi M, Nishioka H, Homma K, Matar C.

Cancer Biol Ther. 2017 Oct 3;18(10):765-774. doi: 10.1080/15384047.2017.1373211. Epub 2017 Sep 8.

17.

Phenolic compounds isolated from fermented blueberry juice decrease hepatocellular glucose output and enhance muscle glucose uptake in cultured murine and human cells.

Nachar A, Eid HM, Vinqvist-Tymchuk M, Vuong T, Kalt W, Matar C, Haddad PS.

BMC Complement Altern Med. 2017 Mar 4;17(1):138. doi: 10.1186/s12906-017-1650-2.

18.

Fermented blueberry juice extract and its specific fractions have an anti-adipogenic effect in 3 T3-L1 cells.

Sánchez-Villavicencio ML, Vinqvist-Tymchuk M, Kalt W, Matar C, Alarcón Aguilar FJ, Escobar Villanueva MD, Haddad PS.

BMC Complement Altern Med. 2017 Jan 6;17(1):24. doi: 10.1186/s12906-016-1519-9.

19.

Age and sex differences in immune response following LPS treatment in mice.

Cai KC, van Mil S, Murray E, Mallet JF, Matar C, Ismail N.

Brain Behav Immun. 2016 Nov;58:327-337. doi: 10.1016/j.bbi.2016.08.002. Epub 2016 Aug 6.

PMID:
27506825
20.

Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation.

Vuong T, Mallet JF, Ouzounova M, Rahbar S, Hernandez-Vargas H, Herceg Z, Matar C.

J Transl Med. 2016 Jan 14;14:13. doi: 10.1186/s12967-016-0770-7.

21.

CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice.

O'Flaherty BM, Matar CG, Wakeman BS, Garcia A, Wilke CA, Courtney CL, Moore BB, Speck SH.

PLoS One. 2015 Aug 28;10(8):e0135719. doi: 10.1371/journal.pone.0135719. eCollection 2015.

22.

Does EBV alter the pathogenesis of malaria?

Matar CG, Jacobs NT, Speck SH, Lamb TJ, Moormann AM.

Parasite Immunol. 2015 Sep;37(9):433-45. doi: 10.1111/pim.12212. Review.

23.

Gammaherpesvirus Co-infection with Malaria Suppresses Anti-parasitic Humoral Immunity.

Matar CG, Anthony NR, O'Flaherty BM, Jacobs NT, Priyamvada L, Engwerda CR, Speck SH, Lamb TJ.

PLoS Pathog. 2015 May 21;11(5):e1004858. doi: 10.1371/journal.ppat.1004858. eCollection 2015 May.

24.

Active Hexose Correlated Compound (AHCC) promotes an intestinal immune response in BALB/c mice and in primary intestinal epithelial cell culture involving toll-like receptors TLR-2 and TLR-4.

Mallet JF, Graham É, Ritz BW, Homma K, Matar C.

Eur J Nutr. 2016 Feb;55(1):139-46. doi: 10.1007/s00394-015-0832-2. Epub 2015 Jan 18.

PMID:
25596849
25.

Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1.

Matar CG, Rangaswamy US, Wakeman BS, Iwakoshi N, Speck SH.

J Virol. 2014 Oct;88(19):11600-10. doi: 10.1128/JVI.01876-14. Epub 2014 Jul 30.

26.

The immunopotentiating effects of shark-derived protein hydrolysate.

Mallet JF, Duarte J, Vinderola G, Anguenot R, Beaulieu M, Matar C.

Nutrition. 2014 Jun;30(6):706-12. doi: 10.1016/j.nut.2013.10.025. Epub 2013 Nov 6.

PMID:
24800670
27.

Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4.

Wong EB, Mallet JF, Duarte J, Matar C, Ritz BW.

Nutr Res. 2014 Apr;34(4):318-25. doi: 10.1016/j.nutres.2014.02.007. Epub 2014 Mar 6.

PMID:
24774068
28.

MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells.

Ouzounova M, Vuong T, Ancey PB, Ferrand M, Durand G, Le-Calvez Kelm F, Croce C, Matar C, Herceg Z, Hernandez-Vargas H.

BMC Genomics. 2013 Feb 28;14:139. doi: 10.1186/1471-2164-14-139.

29.

KBP-cytoskeleton interactions underlie developmental anomalies in Goldberg-Shprintzen syndrome.

Drévillon L, Megarbane A, Demeer B, Matar C, Benit P, Briand-Suleau A, Bodereau V, Ghoumid J, Nasser M, Decrouy X, Doco-Fenzy M, Rustin P, Gaillard D, Goossens M, Giurgea I.

Hum Mol Genet. 2013 Jun 15;22(12):2387-99. doi: 10.1093/hmg/ddt083. Epub 2013 Feb 19.

PMID:
23427148
30.

Variation in endogenous oxidative stress in Escherichia coli natural isolates during growth in urine.

Aubron C, Glodt J, Matar C, Huet O, Borderie D, Dobrindt U, Duranteau J, Denamur E, Conti M, Bouvet O.

BMC Microbiol. 2012 Jun 22;12:120. doi: 10.1186/1471-2180-12-120.

31.

GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models.

Kelly-Aubert M, Trudel S, Fritsch J, Nguyen-Khoa T, Baudouin-Legros M, Moriceau S, Jeanson L, Djouadi F, Matar C, Conti M, Ollero M, Brouillard F, Edelman A.

Hum Mol Genet. 2011 Jul 15;20(14):2745-59. doi: 10.1093/hmg/ddr173. Epub 2011 Apr 25.

PMID:
21518732
32.

Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage.

Huet O, Dupic L, Batteux F, Matar C, Conti M, Chereau C, Lemiale V, Harrois A, Mira JP, Vicaut E, Cariou A, Duranteau J.

Crit Care Med. 2011 Jul;39(7):1712-20. doi: 10.1097/CCM.0b013e3182186d42.

PMID:
21494109
33.

Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds.

Ndiaye F, Vuong T, Duarte J, Aluko RE, Matar C.

Eur J Nutr. 2012 Feb;51(1):29-37. doi: 10.1007/s00394-011-0186-3. Epub 2011 Mar 27.

PMID:
21442413
34.

Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells.

Hernandez-Vargas H, Ouzounova M, Le Calvez-Kelm F, Lambert MP, McKay-Chopin S, Tavtigian SV, Puisieux A, Matar C, Herceg Z.

Epigenetics. 2011 Apr;6(4):428-39.

PMID:
21266853
35.

Salmonella isolates with decreased susceptibility to extended-spectrum cephalosporins in the United States.

Sjölund-Karlsson M, Rickert R, Matar C, Pecic G, Howie RL, Joyce K, Medalla F, Barzilay EJ, Whichard JM.

Foodborne Pathog Dis. 2010 Dec;7(12):1503-9. doi: 10.1089/fpd.2010.0607. Epub 2010 Aug 12.

PMID:
20704496
36.

Biotransformed blueberry juice protects neurons from hydrogen peroxide-induced oxidative stress and mitogen-activated protein kinase pathway alterations.

Vuong T, Matar C, Ramassamy C, Haddad PS.

Br J Nutr. 2010 Sep;104(5):656-63. doi: 10.1017/S0007114510001170. Epub 2010 May 12.

PMID:
20459875
37.

'Desperate house genes': the dramatic example of hypoxia.

Caradec J, Sirab N, Keumeugni C, Moutereau S, Chimingqi M, Matar C, Revaud D, Bah M, Manivet P, Conti M, Loric S.

Br J Cancer. 2010 Mar 16;102(6):1037-43. doi: 10.1038/sj.bjc.6605573. Epub 2010 Feb 23.

38.

Antiobesity and antidiabetic effects of biotransformed blueberry juice in KKA(y) mice.

Vuong T, Benhaddou-Andaloussi A, Brault A, Harbilas D, Martineau LC, Vallerand D, Ramassamy C, Matar C, Haddad PS.

Int J Obes (Lond). 2009 Oct;33(10):1166-73. doi: 10.1038/ijo.2009.149. Epub 2009 Aug 18.

PMID:
19687792
39.

Fermented Canadian lowbush blueberry juice stimulates glucose uptake and AMP-activated protein kinase in insulin-sensitive cultured muscle cells and adipocytes.

Vuong T, Martineau LC, Ramassamy C, Matar C, Haddad PS.

Can J Physiol Pharmacol. 2007 Sep;85(9):956-65.

PMID:
18066143
40.

The application of probiotics in cancer.

de Moreno de LeBlanc A, Matar C, Perdigón G.

Br J Nutr. 2007 Oct;98 Suppl 1:S105-10. Review.

PMID:
17922945
41.
42.

Study of immune cells involved in the antitumor effect of kefir in a murine breast cancer model.

de Moreno de Leblanc A, Matar C, Farnworth E, Perdigón G.

J Dairy Sci. 2007 Apr;90(4):1920-8.

43.

Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity.

Vinderola G, Perdigón G, Duarte J, Farnworth E, Matar C.

Cytokine. 2006 Dec;36(5-6):254-60. Epub 2007 Mar 23.

PMID:
17363262
45.

Mucosal immunomodulation by the non-bacterial fraction of milk fermented by Lactobacillus helveticus R389.

Vinderola G, Matar C, Palacios J, Perdigón G.

Int J Food Microbiol. 2007 Apr 10;115(2):180-6. Epub 2006 Dec 20.

PMID:
17184869
46.
47.

Effects of the oral administration of the products derived from milk fermentation by kefir microflora on immune stimulation.

Vinderola G, Perdigón G, Duarte J, Farnworth E, Matar C.

J Dairy Res. 2006 Nov;73(4):472-9. Epub 2006 Jul 7.

PMID:
16827951
48.

Immunomodulating capacity of commercial fish protein hydrolysate for diet supplementation.

Duarte J, Vinderola G, Ritz B, Perdigón G, Matar C.

Immunobiology. 2006;211(5):341-50. Epub 2006 Apr 27.

PMID:
16716803
49.

Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir.

de Moreno de LeBlanc A, Matar C, Farnworth E, Perdigon G.

Cytokine. 2006 Apr;34(1-2):1-8. Epub 2006 May 12.

PMID:
16697655
50.

Effects of kefir fractions on innate immunity.

Vinderola G, Perdigon G, Duarte J, Thangavel D, Farnworth E, Matar C.

Immunobiology. 2006;211(3):149-56. Epub 2006 Feb 7.

PMID:
16530082

Supplemental Content

Support Center